Imagine telling a cannabis farmer that a simple spray made from dandelion, echinacea, and nettle — applied at exactly the right moment during the plant’s life — could dramatically increase both the size of the harvest and the concentration of medically valuable cannabinoids. It sounds almost too good to be true. But that’s precisely what a new peer-reviewed study, published in March 2026 in the International Journal of Plant Biology, is claiming — and the implications for medicinal cannabis production are genuinely significant.
Key Takeaways
- A plant-based biostimulant called Tricostimulant™ was found to boost CBD content by up to 8.7%, CBG by up to 47.5%, and THC by up to 32% in cannabis plants — without synthetic chemicals.
- Timing is everything: the effects were strongest when the biostimulant was applied during the weed vegetative stage, the early growth phase before flowering begins.
- The biostimulant appears to work in a chemotype-specific way — boosting THC in THC-dominant strains and CBD in CBD-dominant plants, without crossing unwanted lines.
- Cannabis trichomes — the tiny resin glands on flowers where cannabinoids are made — are likely at the center of this effect, though the exact mechanism still needs more research.
- This approach could help standardize medicinal cannabis products and reduce reliance on synthetic agricultural inputs.
The Problem With Cannabis as Medicine: It’s Wildly Inconsistent
If you’ve ever wondered why two batches of medical marijuana can feel completely different even from the same strain, you’re brushing up against one of the industry’s biggest headaches: consistency. Cannabis sativa is a biochemically complex plant. Its flowers can be rich in THC, CBD, CBG, or dozens of other cannabinoids — depending on genetics, soil, weather, light, and dozens of other variables. For recreational users, a bit of variation is tolerable. For patients relying on cannabis-based medicines, it’s a serious problem.
Pharmaceutical-grade products demand precise, reproducible cannabinoid profiles. A medicine that works differently batch to batch isn’t really a medicine — it’s a gamble. This is where the new research steps in with a potentially elegant solution.
What Exactly Is a Biostimulant, and Why Should Growers Care?
Before we get to the results, a quick primer. A biostimulant is any natural substance — derived from plants, microorganisms, or organic matter — that improves a crop’s growth, resilience, or biochemistry without acting as a nutrient or pesticide in the traditional sense. Think of it as a gentle nudge to the plant’s own metabolic machinery.
Biostimulants have already been adopted in lavender, sage, rosemary, and other aromatic crops to enhance essential oil profiles. Applying the same logic to cannabis — one of the most pharmacologically complex plants on Earth — is a logical next step, but one that until now had almost no scientific documentation.
The team at Biotech Tricopharming Research SL, working alongside researchers from Colombia’s Clever Leaves and Spain’s CSIC (the country’s main public research agency), developed a formulation they call Tricostimulant™. It’s a botanical extract containing Centella asiatica (the classic wound-healing herb), Echinacea purpurea, Taraxacum officinale (ordinary dandelion), Urtica dioica (stinging nettle), and fermented rice extract. All natural. All with established histories as plant-supportive compounds in other contexts.
The Experiment: Fields in Spain, Greenhouses in Colombia
The researchers ran three separate trials. The first two took place at Tricopharming’s outdoor plots on Tenerife (Canary Islands), using an industrial hemp variety called Carmagnola Selezionata, legally grown for its CBD-dominant profile. The third was a commercial-scale greenhouse trial at Clever Leaves’ facilities in Colombia, using varieties with clearly contrasting cannabinoid profiles — including two THC-rich chemotypes and one CBD-dominant strain.
In all trials, plants were sprayed once with Tricostimulant™ at a dilution of 2 mL per liter of water. The key variable tested was timing: was it better to apply the biostimulant during the vegetative stage (when the plant is focused on leaf and stem growth), just before flowering (pre-anthesis), or after flowers had already formed (post-anthesis)?
The answer turned out to be unambiguous.
Timing Is Everything: Why the Weed Vegetative Stage Is the Sweet Spot
Plants treated during the vegetative growth phase showed by far the most dramatic response — both in physical size and in cannabinoid content. By harvest time, they were significantly taller, had heavier stems, and produced cannabinoid profiles clearly different from untreated control plants.
In the CBD-dominant hemp variety, treated plants showed CBD-A (the acidic precursor to CBD) levels 31.82% higher than controls, CBD itself up 8.70%, and — most strikingly — CBG levels up 47.54%. This last finding is particularly noteworthy given growing scientific and commercial interest in CBG as a therapeutic compound, with research suggesting CBG for pain management and anti-inflammatory applications showing genuine promise.
Pre-anthesis application produced moderate effects. Post-anthesis treatment showed essentially nothing. The window of opportunity, it seems, opens during early development and closes fast.
The Chemotype Puzzle: Smart Enough to Know What Each Plant Needs?
Perhaps the most scientifically intriguing finding from the Colombian greenhouse trial was the apparent chemotype-specificity of the effect. When Tricostimulant™ was applied to THC-dominant strains, THC values went up — without any meaningful change in CBD. When applied to the CBD-rich variety, CBD increased — with THC remaining unchanged and well below legal thresholds.
The researchers hypothesize that the biostimulant may work by boosting the metabolic flow toward CBGA — cannabigerolic acid — the universal precursor from which all major cannabinoids are synthesized inside cannabis trichomes. Each plant variety then routes that enhanced CBGA supply through its own genetically determined enzymatic pathways, producing more of whatever cannabinoid it’s already naturally inclined to make.
If this mechanism holds up under more rigorous testing, it would represent a remarkable piece of biological precision — a single spray that amplifies what’s already there, rather than forcing the plant in any particular direction. For growers aiming to produce the highest THC strain possible, or conversely, a maximally CBD-rich hemp cultivar, this could become an invaluable tool in the grow room. It’s worth noting that Tricostimulant™ is not the only natural compound showing this kind of targeted pre-harvest influence: as we covered recently, salicylic acid has also been shown to selectively boost THCA and THC levels in cannabis ahead of harvest — suggesting a broader trend toward natural chemical priming as a cultivation strategy.
What About the Trichomes?
Anyone who’s examined cannabis flowers up close knows about cannabis trichomes — those tiny, mushroom-shaped crystal structures that coat the surface of mature buds and nearby leaves. They’re the factories where cannabinoids are synthesized and stored. Understanding when trichomes are ready to harvest has long been considered an art as much as a science (clear trichomes mean immature; milky white means peak THC; amber trichomes signal degradation beginning). That judgment call is getting more precise all the time — a 2026 study we reported on recently shows how AI is now being trained to read trichome maturity and optimize harvest timing with a level of consistency no human eye can match.
The current study strongly implies that Tricostimulant™ is doing something useful at the level of these structures — either increasing trichome density, ramping up biosynthetic activity inside existing trichomes, or both. But the researchers are honest about the gap: they haven’t directly measured trichome numbers or activity yet. That’s high on the list for future work, along with gene expression studies, enzyme activity analysis, and detailed metabolomics.
Sustainable Farming Meets Precision Medicine
Beyond the cannabinoid numbers, there’s a broader story here about where agricultural science is heading. The global cannabis industry faces pressure from multiple directions simultaneously: tightening regulations on THC content, growing demand for pharmaceutical consistency, environmental scrutiny of chemical-intensive cultivation, and fierce economic competition.
Biostimulants offer a path that threads several needles at once. Unlike conventional flowering nutrients or synthetic growth regulators, they work with the plant’s own biology rather than overriding it. They leave a smaller environmental footprint. And if Tricostimulant™’s apparent selectivity — boosting the dominant cannabinoid of each chemotype without raising regulated compounds above legal thresholds — proves robust in larger trials, it could become a compliance tool as much as a yield tool.
The product is already registered in several EU markets including Spain, Portugal, and the Czech Republic.
What the Research Can’t Yet Tell Us
Science requires honesty about its own limits, and this study provides it. The Colombian trial used pooled samples rather than individual plant replicates, meaning the cannabinoid data from that phase is exploratory rather than statistically proven. The Tenerife trials had small sample sizes (7–8 plants per treatment). And the exact biochemical mechanism of action remains unknown.
The researchers call for future studies with more replicates, molecular analyses, and controlled trials across a wider range of varieties and growing environments. What’s here is genuinely promising — but it’s a starting point, not a final answer.
FAQ
In the trials, THC values in hemp plants (variety Carmagnola Selezionata) treated with Tricostimulant™ remained well below regulatory thresholds — reaching only 0.074% dry weight, far under the EU standard of 0.3%. The researchers specifically note the chemotype-specific effect appears to stay within each plant’s natural metabolic range.
No. Biostimulants like Tricostimulant™ are not fertilizers and do not replace balanced nutrition programs. They work by activating the plant’s own metabolic processes rather than providing macronutrients. A proper feeding schedule — including appropriate flowering nutrients during bloom — remains essential for a healthy crop.
No. Techniques like low stress training and topping weed plants are physical manipulation methods that change plant architecture to improve light distribution and increase bud sites. Biostimulants work at the biochemical level, influencing the plant’s internal metabolic pathways. The two approaches are complementary and could in theory be combined.
The product is already commercially registered in several EU countries. However, availability for individual growers will depend on local regulations governing cannabis cultivation. Interested growers should check local legislation and contact Biotech Tricopharming Research SL directly for commercial inquiries.
Disclaimer: This article is intended for informational and educational purposes only. It is based on a peer-reviewed scientific publication and does not constitute agronomic, medical, or legal advice. Cannabis cultivation is subject to strict national and regional regulations. Always verify the legal status of cannabis growing in your jurisdiction before taking any action. The mention of Tricostimulant™ or any other commercial product does not represent an endorsement by TheCannex.com.